Bratton Capital Management, L.P. - AQUESTIVE THERAPEUTICS INC ownership

AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 47 filers reported holding AQUESTIVE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 2.2%.

Quarter-by-quarter ownership
Bratton Capital Management, L.P. ownership history of AQUESTIVE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,501,766
-90.7%
9,810,9580.0%100.00%0.0%
Q2 2023$16,188,081
+44.7%
9,810,9580.0%100.00%0.0%
Q1 2023$11,184,492
+26.4%
9,810,9580.0%100.00%0.0%
Q4 2022$8,849,484
-22.9%
9,810,9580.0%100.00%0.0%
Q3 2022$11,479,000
+82.8%
9,810,9580.0%100.00%0.0%
Q2 2022$6,279,000
-75.5%
9,810,9580.0%100.00%0.0%
Q1 2022$25,607,000
-32.9%
9,810,9580.0%100.00%0.0%
Q4 2021$38,165,000
-10.8%
9,810,9580.0%100.00%0.0%
Q3 2021$42,776,000
+9.8%
9,810,9580.0%100.00%0.0%
Q2 2021$38,950,000
-23.7%
9,810,9580.0%100.00%0.0%
Q1 2021$51,017,000
-17.1%
9,810,958
-14.7%
100.00%0.0%
Q4 2020$61,543,000
+10.2%
11,503,2940.0%100.00%
+28.7%
Q3 2020$55,848,000
-0.1%
11,503,2940.0%77.67%
-7.3%
Q2 2020$55,906,000
+121.9%
11,503,2940.0%83.77%
+39.3%
Q1 2020$25,192,000
-62.4%
11,503,2940.0%60.15%
-24.9%
Q4 2019$66,949,000
+83.0%
11,503,2940.0%80.13%
+12.1%
Q3 2019$36,580,000
-24.3%
11,503,2940.0%71.47%
+0.7%
Q2 2019$48,313,000
-39.2%
11,503,2940.0%70.95%
-9.3%
Q1 2019$79,487,000
+9.7%
11,503,2940.0%78.22%
+3.0%
Q4 2018$72,471,00011,503,29475.94%
Other shareholders
AQUESTIVE THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Bratton Capital Management, L.P. 11,503,294$61,543,000100.00%
Bracebridge Capital, LLC 428,571$2,293,0000.35%
Oak Grove Capital LLC 59,500$318,0000.10%
Perceptive Advisors 1,385,720$7,414,0000.08%
Virtu Financial LLC 59,050$316,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 152,000$813,0000.02%
OLD MISSION CAPITAL, LLC 32,249$172,0000.01%
Engineers Gate Manager LP 49,000$262,0000.01%
PDT Partners, LLC 16,486$88,0000.01%
CWA Asset Management Group, LLC 11,284$60,0000.01%
View complete list of AQUESTIVE THERAPEUTICS INC shareholders